Jennifer J.D. Morrissette, PhD
Professor of Clinical Pathology and Laboratory Medicine
Perelman School of Medicine at the University of Pennsylvania
Clinical Director, Center for Personalized Diagnostics
Contact InformationDepartment of Pathology and Laboratory Medicine
3020 Market Street, Suite 220
Philadelphia, PA 19104
Office: 215-898-5578
Fax: 215-898-9817
Email: jemorris@pennmedicine.upenn.edu
Specialty Division
Precision and Computational Diagnostics
Education
B.S. (Molecular Biology), State University of New York at Buffalo, 1986
Ph.D. (Molecular Genetics), State University of New York at Buffalo, 1992
Specialty Certification
American Board of Medical Genetics, Clinical Molecular Genetic Diagnostics, 2002
American Board of Medical Genetics, Clinical Cytogenetics, 2002
New York State Certificate of Qualification,
Cytogenetics and Molecular Genetic Diagnostics, 2004
Postgraduate Training
Postdoctoral Fellow, Molecular Genetics, Department of Pathology, Harvard Medical School, Boston MA, 1992-1997
Fellow in Genetics, The Children’s Hospital of Philadelphia, Philadelphia, PA, 1998-2002
Awards and Honors
Mark Diamond Initiative Award, Department of Biological Sciences, State University of New York at Buffalo, 1990
NIH Intramural Research Training Award fellowship, 1992-1993
Pathobiology of Cancer: The Edward A. Smuckler Memorial Workshop, Keystone Colorado, American Association of Cancer Research, 1992
American Social Health Association/Burroughs Wellcome Fund Research Fellowship, 1994-1996
American Association of Cancer Research Fellowship, 1996-1997
General Clinical Research Center (GCRC). Children’s Hospital of Philadelphia, Investigator, 2001-2005
Foerderer Fund for Excellence, Molecular and Cytogenetic Analysis of Autism, 2003-2004
Peter C. Nowell Award in Pathology, University of Pennsylvania, 2013
Memberships and Professional Organizations
American Society Human Genetics, 1998 - 2020
Philadelphia Genetics Group, 2004 - 2018
American College of Medical Genetics, 2005 - Present
American Cytogenetics Conference, 2006 - Present
Children’s Oncology Group, 2007 - 2011
Continuing Education for Cytogenetic Technologists, American Society of Clinical Pathology, 2010 - 2012
Association of Molecular Pathology, 2011 - Present
Novitas Molecular Reimbursement Academic Consortium, 2012 - 2014
Eastern Cooperative Oncology Group (ECOG), 2014 - Present
American Board of Medical Genetics and Genomics (ABMGG), 2017 - 2020
Genomics Organization for Academic Laboratories (GOAL), 2017 - Present
American Society for Clinical Pathology (ASCP) Immuno-Oncology Working Group, 2018 - 2020
International Foundation of Clinical Chemistry and Laboratory Medicine (IFCC)., 2019 - 2024
Item writer ASCP Hematology/Hematopathology RISE/FISHE subcommittee, 2024 - Present
Web Links
Selected Publications
High-Grade Urothelial Carcinoma with Divergent Prostatic Differentiation Mimicking a Collision Tumor in a Bladder Diverticulum.
Budina A, Vergara N, Navarro FE, Morrissette JJD, Nayak A., Int J Surg Pathol. 34(): , 2026, PMID:41918088
Clinical Variant Interpretation with the Integrative Genomics Viewer (IGV) for Molecular Pathologists.
Halper-Stromberg E, Narayan S, Laufer V, Limson M, Busse T, Segal JP, Aisner DL, Morrissette JJD, Thorvaldsdottir H, Robinson JT, Roy S, Tjota MY., J Vis Exp. 14(): , 2026, PMID:42611741
Germline Variants in Centromere Binding Protein 126 Predispose to Glioblastoma.
Renauer P, Marin BM, Melo-Carrillo A, Carpenter M, Zhang L, Nasrallah M, Morrissette J, Brem S, Rong Y, Miller AM, Orringer DA, Bainbridge M, Bondy M, Chen S, Verhaak RGW., medRxiv [Preprint], 2026, PMID:42539028
Myeloid dermatosis with features of sweet syndrome and leukemia cutis: a case report
Patel E, Singh A, Beach D, Morrissette J, Caponetti G., Ann Hematol. 105(): , 2026, PMID:41870653
Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma
Landsburg DJ, Musoke N, Gentile C, Brooks TR, Nasta SD, Barta SK, Carter JS, Chong EA, Svoboda J, Schuster SJ, Thomas CJ, Tomasulo EB, Cook MR, Morrissette JJD, Caimi PF, Hill BT., Leukemia. 10(): , 2026, PMID:41703025
Intra-tumoral Preservation of the Stem-like Malignant Cell Proportion in Glioblastoma, Prognostic Impact, and its Radiomethylomic Signatures
Matsumoto Y, Singh O, Garcia J, Abdullaev Z, Freeburg NF, Yu F, Akbari H, Baik K, Guo J, Shih NNC, Toorens E, Ganguly T, Ballinger D, O'Rourke DM, Mohan S, Morrissette JJD, Silverbush D, Aldape K, Davatzikos C, Nasrallah MP., Neuro Oncol 27(): , 2025, PMID:40726154
Leukemia mutated proteins PHF6 and PHIP form a chromatin complex that represses acute myeloid leukemia stemness
Pawar AS, Somers P, Alex A, Grana J, Feist VK, George SS, Jalnapurkar SS, Antony C, Verner R, White-Brown SK, Khera M, Mendoza-Figueroa MS, Liu KF, Morrissette JJD, Gurbuxani S, Paralkar VR., Genes Dev 39(): 1219-1240, 2025, PMID:40721297
The FBXO45-GEF-H1 axis controls germinal center formation and B-cell lymphomagenesis.
Sahasrabuddhe AA, Chen X, Ma K, Wu R, Liang HC, Kapoor R, Chhipa RR, Onder O, McFetridge C, Van Arnam JS, Zhang X, Morrissette JJD, Pillai V, Li MM, Szankasi P, Basrur V, Conlon KP, Raabe TD, Bailey NG, Hogaboam CM, Rottapel R, Kim J, López C, Schlesner M, Siebert R, Dreval K, Morin RD, Moro L, Pagano M, Staudt LM, Lim MS, Elenitoba-Johnson KSJ., Cancer Discov. 15(): 838-861, 2025, PMID:39820335
ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders.
Sande CM, Chen S, Mitchell DV, Lin P, Abraham DM, Cheng JM, Gebhard T, Deolikar RJ, Freeman C, Zhou M, Kumar S, Bowman M, Bowman RL, Zheng S, Munkhbileg B, Chen Q, Stanley NL, Guo K, Lapite A, Hausler R, Taylor DM, Corines J, Morrissette JJ, Lieberman DB, Yang G, Shestova O, Gill S, Zheng J, Smith-Simmer K, Banaszak LG, Shoger KN, Reinig EF, Peterson M, Nicholas P, Walne AJ, Dokal I, Rosenheck JP, Oetjen KA, Link DC, Gelman AE, Reilly CR, Dutta R, Lindsley RC, Brundige KJ, Agarwal S, Bertuch AA, Churpek JE, Tague LK, Johnson FB, Olson TS, Babushok DV., J Clin Invest 135(): , 2025, PMID:40179146
Persistent post-remission clonal hematopoiesis shapes the relapse trajectories of acute myeloid leukemia
Chow RD, Velu P, Deihimi S, Belman JP, Youn A, Shah N, Luger SM, Carroll MP, Morrissette JJ, Bowman RL., Blood Adv. 9(): 1888-1899, 2025, PMID:39938015
